Prof. Dr. rer. nat. Volker Schirrmacher
Scientific Director
Cancer researcher and immunologist
Prof. Dr. rer. nat. Volker Schirrmacher was appointed to the German Cancer Research Centre (DKFZ) in Heidelberg in 1976 as scientific advisor and professor for immunology. In 1979 he earned his habilitation in immunology in Heidelberg and in 1986 he became a full professor. At the DKFZ he was head of the Department of Cellular Immunology until his retirement in 2008.
In 2008, he was appointed Scientific Director of Tumour Immunology at the IOZK. His scientific work comprises almost 400 publications in international journals.
In 1987 and 1988 he was chairman of the Experimental Cancer Research Section at the German Cancer Society and in 1989/80 president of the Metastasis Research Society. In 2003 and 2004 he represented Germany at the European Association of Cancer Research (EACR). From 2009 to 2011 he was President of the European Society for Applied Immunology (EGAI).
In 1982 he was awarded the Aronson Prize and the Meyenburg Prize and in 1988 the German Cancer Prize.
He is an internationally recognised pioneer of immunotherapy in cancer with a focus on oncolytic viruses. Together with the scientists and physicians at the IOZK, he works on the systematic integration of new scientific findings for the further development of the IOZK immunotherapy.
“Viruses are known as the cause of various diseases. Lesser known, however, is the use of viruses in the treatment of cancer. Over a hundred years ago, medicine first observed that patients were cured from the symptoms of cancer after a viral infection.”
Prof. Dr. rer. nat. Volker Schirrmacher
Compilation: Scientific contributions and international publications by Volker Schirrmacher
Más información sobre este tema:
This post is also available in: German Spanish Russian
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
/in IOZK at conferencesInternational Journal of Oncology: “From chemotherapy to biological therapy”, Prof. Dr. Volker Schirrmacher
/in IOZK in the press, IOZK publicationsIOZK presentation: Modulated electro-hyperthermia in the treatment of children with DIPG at the annual conference of the ESHO at the Charité in Berlin
/in IOZK announcements, IOZK at conferencesBook published by Prof. Dr. Schirrmacher: Quo vadis cancer therapy
/in IOZK announcements, IOZK publicationsIOZK publication in the International Journal of Molecular Sciences by Prof. Schirrmacher focusing on the role of Newcastle Disease Virus in tumor vaccinations
/in IOZK in the press, IOZK publicationsIOZK publication in Austin Oncology Case Reports on anti-tumor vaccines
/in IOZK in the press, IOZK publicationsPublication by Prof Schirrmacher in Biomedicines: “Fifty Years of Clinical Application of Newcastle Disease Virus”
/in IOZK announcements, IOZK publications